To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…
Ended Awarded Last action
- Contract number
- 75N91021F00076
- Awardee
-
Asclepius Solutions Inc. UEI LKVVZXZFRHM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$0
Award facts
- Contract value 0% obligated
- $110,151.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Original award | $110,151 |
About this award
The National Cancer Institute (NCI), a civilian agency within the National Institutes of Health, awarded a delivery order valued at $110,151.36 to Asclepius Solutions Inc., a Service Disabled Veteran-Owned Small Business certified woman-owned small business, on February 24, 2021. The delivery order was issued under the 8(a) Streamlined Technology Acquisition Resources for Services (8a STARS II) GWAC, a governmentwide acquisition contract vehicle designed to provide federal agencies with access to information technology professional services and cloud computing solutions from certified 8(a) small businesses. The contract carries a Competitive 8(a) set-aside designation and operates under firm fixed-price terms with an ultimate completion date of August 31, 2021. Work will be performed at the NCI's facilities in Bethesda, Maryland.
This delivery order serves to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the funds' period of availability. Asclepius Solutions brings substantial relevant experience supporting NCI's research programs, having previously delivered professional services, mobile application development, project management, application support, cloud systems support, and data management through both sole source 8(a) awards and the company's General Services Administration Multiple Award Schedule contract. The firm holds an active GSA Schedule contract vehicle extending through September 2025, enabling continued provision of technology-agnostic informatics solutions to support federal research and business initiatives.
Description
To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds.
Quick answers
Who was awarded contract 75N91021F00076?
75N91021F00076 was awarded to Asclepius Solutions Inc. by National Cancer Institute (National Institutes of Health) on February 24, 2021.
How much is contract 75N91021F00076 worth?
The government has obligated -$0 on 75N91021F00076. Its current value, with exercised options, is $110,151.
Is contract 75N91021F00076 an order under another contract?
Yes. 75N91021F00076 is a delivery order under GS06F1077Z, a government wide acquisition contract (GWAC), on 8a Streamlined Technology Acquisition Resources for Services (8a STARS II).
Was contract 75N91021F00076 competed?
The extent of competition for 75N91021F00076 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award